Kevin is a seasoned pharmaceutical executive and consultant with extensive expertise in CMC, technical innovation, and business development. Over his career, he has led critical programs, including advancing Hepatitis-C treatments to market and implementing continuous manufacturing technologies. As a trusted advisor, Kevin excels in navigating regulatory landscapes, enhancing operational efficiencies, and accelerating the development timeline from lab to market.
